Óstáilte ar MSNLíon na míonna: 10
BridgeBio grants Japanese rights to Kyowa Kirin for dwarfism drug
BridgeBio (NASDAQ:BBIO) has granted an exclusive license to Kyowa Kirin for the Japanese development and commercialization rights to its dwarfism drug infigratinib. Under the deal, Kyowa Kirin ...